University of Tennessee secures $20 million NSF grant to pioneer breakthroughs in automated materials discovery
Meeting Announcement
WASHINGTON — Free media registration is now open for Neuroscience 2026, the largest and most influential gathering of brain scientists and clinicians in the world. This year’s annual meeting will take place November 14–18 at the Walter E. Washington Convention Center in Washington, D.C., and online.
Discover the future of healthcare and neurotechnology at the University of Rhode Island’s Advances in Translational Neurotechnologies for Healthcare and Rehabilitation Symposium. This exciting one-day event will bring together leading researchers, clinicians, faculty, industry innovators, and students to explore groundbreaking advances at the intersection of engineering, neuroscience, healthcare, and rehabilitation, organized by URI associate professor of biomedical engineering Yalda Shahriari, chair of the symposium, and URI assistant professor of biomedical engineering Reza Abiri, symposium co-chair.
Taking place Friday, Aug. 14, at the Fascitelli Center for Advanced Engineering on the University of Rhode Island’s Kingston Campus, the symposium will feature distinguished speakers, cutting-edge research presentations, interactive discussions, and valuable networking opportunities designed to foster collaboration and accelerate the translation of emerging neurotechnologies into real-world healthcare solutions.
People’s Medical Publishing House organized a symposium on medical journal development. The event also marked the first meeting of Global Health Journal’s newly constituted 4th editorial board. In the event, prominent academics and industry experts discussed new methods to make Chinese medical research more accessible and reputable around the world.
Built on the open-access publishing platform of NEW HORIZON PRESS LIMITED, NEW Community engaged in international outreach and scholarly exchange during the 2026 international geochemistry conference. Its activities centered on emerging topics including AI-ready geochemical data, carbon removal, enhanced rock weathering, biogeochemical cycles, contaminant transport and transformation, and climate change, with the aim of fostering interdisciplinary research networks.
Dr. Alex Zhavoronkov, Founder and Co-CEO of Insilico Medicine, and Dr. Feng Ren, Co-CEO and Chief Scientific Officer, have been invited to attend the inaugural China Pioneer Innovative Drug Global Congress (CPIC 2026), which will grandly convene at the National Exhibition and Convention Center (Shanghai) from July 22 to 24. During this premier event, the two industry leaders will appear at several high-profile forums to deliver keynote speeches, sharing deep insights on how cutting-edge AI combines with "China Speed" to decode the mysteries of life and reshape the global drug R&D landscape.